BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37236758)

  • 21. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
    Fleming I
    Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eicosanoids and Oxidative Stress in Diabetic Retinopathy.
    Wang MH; Hsiao G; Al-Shabrawey M
    Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32545552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X; Zhang XA; Wang DW
    Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies.
    Guan XX; Rao DN; Liu YZ; Zhou Y; Yang HH
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.
    Aliwarga T; Dinh JC; Heyward S; Prasad B; Gharib SA; Lemaitre RN; Sotoodehnia N; Totah RA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
    Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
    Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo.
    Aliwarga T; Raccor BS; Lemaitre RN; Sotoodehnia N; Gharib SA; Xu L; Totah RA
    Free Radic Biol Med; 2017 Nov; 112():131-140. PubMed ID: 28734877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
    Sun J; Sui X; Bradbury JA; Zeldin DC; Conte MS; Liao JK
    Circ Res; 2002 May; 90(9):1020-7. PubMed ID: 12016269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eicosanoids, β-cell function, and diabetes.
    Luo P; Wang MH
    Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):1-10. PubMed ID: 21757024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The roles of cytochrome P450 metabolites of arachidonic acid in the regulation of vascular function].
    Lai JS; Chen C
    Sheng Li Xue Bao; 2021 Aug; 73(4):631-645. PubMed ID: 34405219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450-derived eicosanoids and heart function.
    Jamieson KL; Endo T; Darwesh AM; Samokhvalov V; Seubert JM
    Pharmacol Ther; 2017 Nov; 179():47-83. PubMed ID: 28551025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of cytochrome p450 in ischemic heart disease.
    Sato M; Yokoyama U; Fujita T; Okumura S; Ishikawa Y
    Curr Drug Metab; 2011 Jul; 12(6):526-32. PubMed ID: 21476972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
    Spiecker M; Liao JK
    Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450-derived eicosanoids and inflammation in liver diseases.
    Shoieb SM; El-Ghiaty MA; Alqahtani MA; El-Kadi AOS
    Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106400. PubMed ID: 31733338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 eicosanoids and cerebral vascular function.
    Imig JD; Simpkins AN; Renic M; Harder DR
    Expert Rev Mol Med; 2011 Mar; 13():e7. PubMed ID: 21356152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy.
    El-Sherbeni AA; El-Kadi AO
    Biochem Pharmacol; 2014 Feb; 87(3):456-66. PubMed ID: 24300133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted analysis of eicosanoids derived from cytochrome P450 pathway by high-resolution multiple-reaction monitoring mass spectrometry.
    Acunha T; Nardini V; Peti APF; Prado MKB; Moraes LAB; Faccioli LH
    J Mass Spectrom; 2021 Jul; 56(7):e4769. PubMed ID: 34120382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epoxyeicosanoid signaling in CNS function and disease.
    Iliff JJ; Jia J; Nelson J; Goyagi T; Klaus J; Alkayed NJ
    Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):68-84. PubMed ID: 19545642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
    Deng Y; Theken KN; Lee CR
    J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.